Genomic Health Innovators: Leaders in Pharmacogenomics
Added: (Wed Mar 13 2024)
Pressbox (Press Release) -
The global pharmacogenomics market is on a trajectory to exceed $19.5 billion by 2031, showcasing a robust Compound Annual Growth Rate (CAGR) of 8.9% during the forecast period of 2024–2031. This growth is underpinned by various factors including the expanding therapeutic applications of pharmacogenomic biomarkers, rising adoption of personalized medicines, increasing geriatric population, prevalence of chronic diseases, and the endorsement by regulatory bodies like the U.S. FDA and EMA for integrating pharmacogenomic data in drug discovery and development processes. Additionally, the market's upward trajectory is fueled by the escalating utilization of pharmacogenomics in treating neurological disorders and cancers, advancements in diagnostic tools with enhanced precision, and heightened awareness regarding adverse drug reactions, thereby opening up lucrative opportunities for stakeholders in this domain.
Top 10 Companies Driving Pharmacogenomics Market Growth @ https://meticulousblog.org/top-10-companies-in-pharmacogenomics-market/
1. Thermo Fisher Scientific Inc. (U.S.): A stalwart in the industry since 1956, Thermo Fisher Scientific offers a comprehensive suite of products and services catering to various sectors including pharmaceuticals, biotechnology, clinical, and healthcare. With a robust presence across continents, the company is a key player in the pharmacogenomics market, providing innovative solutions through its Life Sciences Solutions and Analytical Instruments segments.
2. Agilent Technologies, Inc. (U.S.): Established in 1999, Agilent Technologies is renowned for its cutting-edge technology solutions in testing and innovation. Operating through three business segments, the company is a significant contributor to the pharmacogenomics market, offering a spectrum of software, consumables, and instruments tailored for laboratory workflows.
3. Illumina, Inc. (U.S.): Pioneering genomic and genetic analysis since its inception in 1998, Illumina is a global leader in sequencing- and array-based solutions. With a focus on enhancing early cancer detection and genetic analysis, the company's Core Illumina segment plays a pivotal role in advancing pharmacogenomic research and applications.
4. Qiagen N.V. (Netherlands): Established in 1984, Qiagen N.V. stands at the forefront of sample and assay technologies for molecular diagnostics and research. With a global footprint spanning over 130 countries, the company offers an array of PCR/Nucleic acid amplification solutions, catering to the diverse needs of the pharmacogenomics market.
5. Danaher Corporation (U.S.): A beacon of innovation in science and technology, Danaher Corporation boasts a diverse portfolio of operating companies. With a significant presence in life sciences and diagnostics, the company provides a range of pharmacogenomics products including instruments and genomic sample preparation solutions.
6. Bio-Rad Laboratories, Inc. (U.S.): With a rich legacy dating back to 1952, Bio-Rad Laboratories is synonymous with breakthrough products in life science research and clinical diagnostics. Operating across two segments, the company's offerings in genetic material purification and amplification are instrumental in advancing pharmacogenomic research.
Download Sample Report Here @ https://www.meticulousresearch.com/download-sample-report/cp_id=5366
7. PerkinElmer, Inc. (U.S.): Established in 1937, PerkinElmer is a global powerhouse in providing solutions for life sciences, diagnostics, and applied markets. With a strong emphasis on discovery and analytical solutions, the company's contributions to mass spectrometry and nucleic acid isolation technologies are pivotal in driving pharmacogenomics advancements.
8. F. Hoffmann-La Roche (Switzerland): A beacon of innovation since 1896, F. Hoffmann-La Roche is renowned for its transformative medicines and diagnostics solutions. With a focus on companion diagnostic assays and sequencing instruments, the company's offerings play a vital role in shaping the pharmacogenomics landscape.
9. Pacific Biosciences of California, Inc. (U.S.): Founded in 2004, Pacific Biosciences is a frontrunner in life science technology, specializing in sequencing solutions. With a focus on HiFi long-read sequencing technology, the company's products cater to a broad spectrum of applications including pharmacogenomics research.
About Meticulous Research®
Meticulous Research® was founded in 2010 and incorporated as Meticulous Market Research Pvt. Ltd. in 2013 as a private limited company under the Companies Act, 1956. Since its incorporation, the company has become the leading provider of premium market intelligence in North America, Europe, Asia-Pacific, Latin America, and the Middle East & Africa.
The name of our company defines our services, strengths, and values. Since the inception, we have only thrived to research, analyze, and present the critical market data with great attention to details. With the meticulous primary and secondary research techniques, we have built strong capabilities in data collection, interpretation, and analysis of data including qualitative and quantitative research with the finest team of analysts. We design our meticulously analyzed intelligent and value-driven syndicate market research reports, custom studies, quick turnaround research, and consulting solutions to address business challenges of sustainable growth.
Contact Us:
Meticulous Research®
Email- sales@meticulousresearch.com
Contact Sales- +1-646-781-8004
Connect with us on LinkedIn- https://www.linkedin.com/company/meticulous-research